Consolidated cash flow statements
(thousands of €) |
2020 |
2019 |
Notes |
Net profit/loss (-) of the year |
(305,436) |
149,845 |
|
|
|
|
|
Adjustment for non-cash transactions |
230,723 |
248,027 |
|
Adjustment for items to disclose separately under operating cash flow |
4,067 |
(7,731) |
|
Adjustment for items to disclose under investing and financing cash flows |
(2,472) |
(5,061) |
|
Change in working capital other than deferred income |
(146,092) |
12,698 |
|
Increase/decrease (-) in deferred income |
(207,787) |
2,804,202 |
|
|
|
|
|
Cash generated/used (-) in operations |
(426,998) |
3,201,980 |
|
|
|
|
|
Interest paid |
(9,033) |
(1,158) |
|
Interest received |
10,054 |
7,852 |
|
Corporate taxes paid |
(1,358) |
(57) |
|
|
|
|
|
Net cash flows generated/used (-) in operating activities |
(427,336) |
3,208,617 |
|
|
|
|
|
Purchase of property, plant and equipment |
(42,522) |
(22,385) |
|
Purchase of and expenditure in intangible fixed assets |
(48,793) |
(23,300) |
|
Proceeds from disposal of property, plant and equipment |
49 |
- |
|
Purchase of current financial investments |
(4,574,206) |
(4,787,284) |
|
Interest received related to current financial investments |
3,500 |
5,059 |
|
Sale of current financial investments |
5,415,316 |
1,063,344 |
|
Acquisition of financial assets |
(2,681) |
(177) |
|
Proceeds from sale of financial assets held at fair value through profit or loss |
6,626 |
82 |
|
|
|
|
|
Net cash flows generated/used (-) in investing activities |
757,288 |
(3,764,660) |
|
|
|
|
|
Payment of lease liabilities |
(6,247) |
(5,091) |
|
Proceeds from capital and share premium increases, gross amount |
- |
960,087 |
|
Issue costs paid related to capital and share premium increases |
- |
(4,447) |
|
Proceeds from capital and share premium increases from exercise of subscription rights |
28,287 |
17,167 |
|
Proceeds from capital and share premium increases from exercise of warrant A by Gilead |
- |
368,035 |
|
|
|
|
|
Net cash flows generated in financing activities |
22,040 |
1,335,751 |
|
|
|
|
|
Increase in cash and cash equivalents |
351,994 |
779,708 |
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at beginning of year |
1,861,616 |
1,290,796 |
|
|
|
|
|
Transfer to current financial investments |
- |
(198,922) |
|
|
|
|
|
Increase in cash and cash equivalents |
351,994 |
779,708 |
|
|
|
|
|
Effect of exchange rate differences on cash and cash equivalents |
(70,539) |
(9,966) |
|
|
|
|
|
Cash and cash equivalents at end of the year |
2,143,071 |
1,861,616 |
The accompanying notes form an integral part of these financial statements.